VI. Miscellaneous (? Dysgenetic testes ? teratogenic factors)

САН =congenital adrenal hyperplasia; TST = testosterone; АМН = anti-Mullerian hormone; DHTST = dihydrotestosterone.

10.2.1 Ovary only (female pseudohermaphrodite)

46XX patients with normal ovaries and uterus, with virilized external genitalia due to the endogenous overproduction of androgens by the foetal adrenal glands (САН, AGS). These patients account for approximately two-thirds of intersex states in clinical practice.

10.2.2 Testis only (male pseudohermaphrodite)

46XY patients with inadequate virilization of the external genitalia due to deficient biosynthesis of TST, inadequate conversion of TST to DHTST (lack of 5a-reductase) or inadequate TST/DHTST utilization (lack of androgen receptors). Also patients with АМН deficiency with adequate male external genitalia and retained Mullerian structures, i.e. tubes and uterus (hernia uteri inguinalis).

10.2.3 Testis plus ovary (true hermaphrodite)

Patients possess both ovarian and testicular tissue in various combinations. Their karyotype varies, i.e. 46XX, 46XY or mosaic 46XX/46XY. True hermaphrodites make up approximately 10% of intersex cases.

10.2.4 Testis plus streak gonad (mixed gonadal dysgenesis)

The second most common category of intersexuality. Most common karyotype 45XO/46XY mosaicism. The existing testis is infertile and Mullerian structures may be present on both sides. There is a high risk of gonadoblastoma of the existing testis after puberty.

10.2.5 Streak plus streak (pure gonadal dysgenesis)

Phenotypic females with bilateral gonadal streaks with three subgroups of karyotypes: 45X0 (Turner's syndrome), 46XX and 46XY. The latter subgroup is particularly prone to malignant degeneration of the streak gonads.

10.3 DIAGNOSIS

10.3.1 The neonatal emergency

The first step is to explain the situation to the parents fully and kindly, and delay registering and naming the newborn as long as this is necessary. A careful family history must be taken and the baby carefully examined.

Table 18: Diagnostic work up of neonates with ambiguous genitalia

Good history (family, maternal, neonatal)

Parental consanguinity

Previous intersex disorders or genital anomalies

Previous neonatal deaths

Primary amenorrhoea or infertility in other family members

Maternal exposure to androgens

Failure to thrive, vomiting, diarrhoea of the neonate Physical examination

Pigmentation of genital and areolar area

Hypospadias or sinus urogenitalis

Size of phallus

Palpable and/or symmetrical gonads

Blood pressure Investigations

Buccal smear

Blood: 17-hydroxyprogesterone, electrolytes, LH, FSH, TST, Cortisol, ACTH

Urine: adrenal steroids

Karyotype

Ultrasound

Genitogram

HCG stimulation test

Androgen binding studies

Endoscopy

LH= luteinizing hormone; FSH = follicle stimulating hormone; TST = testosterone; HCG = human chorionic gonadotrophin ACTH = adrenocortico tropic hormone

It must be remembered that if one can feel a gonad it is almost certainly a testis, therefore this clinical finding virtually excludes female pseudohermaphrodites (i.e. САН). The following laboratory investigations are mandatory:

• Buccal smear (if available with accuracy)

• Plasma 17-OH-progesteron assay

• Plasma electrolytes

These investigations will give evidence of САН, which is the most frequent intersex disorder, and if this is the case no further investigation is needed. Otherwise the laboratory work up proceeds accordingly. The HCG stimulation test is particularly helpful in differentiating the main syndromes of male pseudohermaphrodites and in evaluating Leydig cell potential and phallic growth potential.

HCG stimulation test in male pseudohermaphrodites:

• Normal increase in both TST and DHTST = androgen insensitivity syndrome

• Subnormal increase in both TST and DHTST with increasing androgen precursors = TST biosynthetic block

• Normal increase in TST but subnormal increase in DHTST = 5a reductase deficiency.

The following rules of thumb can be applied regarding a precise diagnosis:

• Positive buccal smear test and no palpable gonads is САН or female pseudohermaphrodite due to maternal exposure to androgens. In the case of САН, immediate medical therapy must be instituted (corticosteroid substitution, electrolyte and blood pressure monitoring).

• Negative buccal smear test and one or two gonads palpable (more often inguinal) - if there are Mullerian duct structures, then the anomaly concerns gonadal dysgenesis or true hermaphroditism; if there are no Mullerian duct structures, the anomaly concerns a male hermaphrodite due either to abnormal TST biosynthesis, inadequate conversion of TST to DHTST (5a-reductase deficiency) or receptor anomaly (androgen insensitivity syndrome)

The decision for appropriate sex assignment is taken on account of a precise aetiological diagnosis and the functional potential of the genitalia. Schematically this practical outline can be applied:

• Female pseudohermaphrodites (i.e. САН) should be reared as female since genitoplasty can correct virilization, and spontaneous puberty, sexual intercourse and fertility are to be expected.

• Male pseudohermaphrodites with an inadequate phallus should be given androgenotherapy, i.e. TST, and those with a poor clinical response should be reared as girls. The only exception is 5a-reductase deficiency patients, if recognized, in whom a masculine puberty is expected and may be reared as male.

• True hermaphrodites are preferably reared as girls as they have adequate Mullerian structures, i.e. vagina.

• Mixed gonadal dysgenesis patients with inadequate phallus and intra-abdominal testis are preferably reared as girls. Male sex may, however, be chosen when the phallus has adequate size and cavernosum and the testis is palpable, inguinal or scrotal,

• Pure gonadal dysgenesis patients are reared as girls.